Meet GOLD's next catalyst – Reshema Kemps-Polanco - European Medical Journal

Meet GOLD’s next catalyst – Reshema Kemps-Polanco

EMJ GOLD
Season 03: episode 07

In this week’s episode, Helena and Isabel share an interview with GOLD’s next Catalyst Reshema Kemps-Polanco, Executive Vice President and US Head, Novartis Oncology.

In this special extended version of the interview exclusive to the podcast, hear Reshema’s story and insights in full, including the life experiences that have led her to where she is today, her ideas for tackling clinical trial recruitment gaps, why equal representation matters and so much more.

A little more on GOLD’s guest…

Reshema Kemps-Polanco is Executive Vice President and US Head, Novartis Oncology, where she is responsible for all commercial and medical operations in the US. Starting out her career at Novartis, she initially spent 15 years in various positions and ultimately leading multiple marketing teams within oncology and general medicines. She also served as Assistant to the CEO and Head of North America at Novartis and held other commercial roles of increasing responsibility across multiple therapeutic areas. Reshema then spent six years at J&J, latterly as President, Cardiovascular and Metabolism, and President, Janssen Pharmaceuticals, Puerto Rico, before rejoining Novartis in her current role in 2021.

Reshema has been recognised by the Healthcare Businesswomen’s Association as a Rising Star, by The Network Journal as a top 40 Under 40 achiever and most recently by Savoy Magazine as one of the Most Influential Black Executives in Corporate America. She also proudly served her country as a member of the US Army.

Please rate the quality of this content

As you found this content interesting...

Follow us on social media!

We are sorry that this content was not interesting for you!

Let us improve this content!

Tell us how we can improve this content?

Keep your finger on the pulse

Join Now

Elevating the Quality of Healthcare Globally

>